NCT04857411 is a NA clinical trial of Peers LEAD plus HLWD in Diabetes Mellitus, Type 2, sponsored by University of Wisconsin, Madison.

Who is sponsoring NCT04857411?

NCT04857411 is sponsored by University of Wisconsin, Madison.

What drugs are being tested in NCT04857411?

Interventions in NCT04857411: Peers LEAD plus HLWD.

What condition does NCT04857411 study?

NCT04857411 studies Diabetes Mellitus, Type 2.

Is NCT04857411 still recruiting?

NCT04857411 is currently completed. Last updated 14 February 2022.

Last reviewed 2022-02-14 · How we verify

NCT04857411

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Peers LEAD Plus Healthy Living With Diabetes (HLWD)

Completed NA Last updated 14 February 2022

What this trial tests

NA trial testing Peers LEAD plus HLWD in Diabetes Mellitus, Type 2 in 8 participants. Completed in 22 November 2021.

Timeline

19 April 2021

Primary endpoint
22 November 2021

22 November 2021

Quick facts

Lead sponsor	University of Wisconsin, Madison
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	health services research
Enrollment	8
Start date	19 April 2021
Primary completion	22 November 2021
Estimated completion	22 November 2021
Sites	1 location across United States

Drugs / interventions tested

Peers LEAD plus HLWD

Conditions studied

Diabetes Mellitus, Type 2 — all drugs for Diabetes Mellitus, Type 2 →

Sponsor

University of Wisconsin, Madison

Who can join

Adults 20 to 90, any sex, with Diabetes Mellitus, Type 2. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The specific goal of this project is to decrease diabetes-related morbidity among African Americans (AAs) in Milwaukee through the integration of Peers LEAD, a culturally-appropriate program to increase medication adherence into Healthy Living with Diabetes (HLWD), an existing diabetes self-management program.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

A Culturally Tailored Diabetes Self-Management Intervention Incorporating Race-Congruent Peer Support to Address Beliefs, Medication Adherence and Diabetes Control in African Americans: A Pilot Feasibility Study.
Shiyanbola OO, Maurer M, Schwerer L, Sarkarati N, et al · · 2022 · cited 23× · PMID 36317056 · DOI 10.2147/ppa.s384974

Verify or expand the search:

Other recruiting trials for Diabetes Mellitus, Type 2

Currently open trials in the same condition.

NCT07415954 — A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 · Phase 2 · recruiting
NCT07532863 — A Real-world Study to Investigate Cardiovascular Risk Profile Among Newly Diagnosed Type 2 Diabetes Mellitus (T2DM) Part · recruiting
NCT07336329 — Continuous Glucose Monitoring in Non-Insulin Treated Type 2 Diabetes: Continuous vs. Periodic Use · NA · recruiting
NCT07242469 — A Clinical Trial of MK-1403 in Participants With Type 2 Diabetes Mellitus (MK-1403-006) · Phase 1 · recruiting
NCT07444203 — Transformative Research in Diabetic Nephropathy 2.0 · recruiting

Other University of Wisconsin, Madison trials

Trials by the same sponsor.

NCT07440004 — Testing a Digital Mindfulness Program to Support People Experiencing Suicidal Thoughts · Phase 1 · recruiting
NCT07278466 — The COMParing App Support Strategies Study · NA · recruiting
NCT07475104 — Redesigning Surgical Care for Patients in Wisconsin · NA · enrolling by invitation
NCT07470723 — The ORIGIN-FH Study · NA · recruiting
NCT06975657 — Well-being Skills for Reentry · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04857411 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Wisconsin, Madison
Last refreshed: 14 February 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04857411.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing